Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6CP3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,681
Award facts
- Contract value 100% obligated
- $30,680.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $30,680.79 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens in 0.75 mL quantities. This non-set-aside competitive award was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. As a major pharmaceutical distributor with extensive federal contract experience, the company maintains a diverse portfolio of medical product deliveries encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The Wegovy delivery order represents one of numerous competitively awarded transactions that demonstrate AmerisourceBergen's capability to fulfill federal medical supply requirements across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables the company to supply pharmaceutical products supporting military healthcare programs globally, including Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6CP3?
SPE2DR26F6CP3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F6CP3 worth?
The government has obligated $30,681 on SPE2DR26F6CP3.
Is contract SPE2DR26F6CP3 an order under another contract?
Yes. SPE2DR26F6CP3 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6CP3 competed?
The extent of competition for SPE2DR26F6CP3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award